Our Top Course
React Js
(15 Reviews)
$15 $25
Java Program
(15 Reviews)
$10 $40
Web Design
(15 Reviews)
$10 $20
Web Design
(15 Reviews)
$20 $40

Your shopping cart

Research Details

Early Testing of Alzheimer's using Biomarkers

Early Testing of Alzheimer's using Biomarkers

This paper covers the biomarkers that can be used to test for and diagnose Alzheimer’s Disease. This is important due to the large number of people globally who are suffering from this disease. Two types of biomarker origins were explored here: blood and cerebrospinal fluid. Currently, the standard for testing Alzheimer’s biomarkers is through the use of cerebrospinal fluid collection. These are the biomarkers that have been thoroughly tested and accepted as accurate and reliable, such as Aβ (1-42) and Tau-related proteins. There are also possible biomarkers found in blood. These include Aβ-related proteins, Tau-related enzymes, as well as inflammatory markers. It has been concluded that the most reliable source of biomarker testing is cerebrospinal fluid. However, there have been significant advancements in studies showing that the use of blood may one day become a very real possibility for routine testing. Until then, it is best to keep a healthy lifestyle that will aid in the prevention of this disease.

 

By: Kiranpreet Utal

 

DOI Link: https://doi.org/10.47611/jsrhs.v11i4.3670